Article
Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
24 Jan 2022
Abstract excerpt
Osteosarcoma (OS) is the most common type of primary malignant bone tumor. The high-throughput sequencing technology has shown potential abilities to illuminate the pathogenic genes in OS. This study was designed to find a powerful gene signature that can predict clinical outcomes. We selected OS cases with gene expression and survival data in the TARGET-OS dataset and GSE21257 datasets as training cohort and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
